# Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI

> **NCT00611195** · PHASE4 · COMPLETED · sponsor: **Thomas Erb** · enrollment: 62 (actual)

## Conditions studied

- Upper Respiratory Infections

## Interventions

- **DRUG:** propofol, remifentanil

## Key facts

- **NCT ID:** NCT00611195
- **Lead sponsor:** Thomas Erb
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611195, "Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00611195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*